Latest News about ABBV
Recent news which mentions ABBV
From Benzinga
From MarketWatch
What Will AbbVie Buy Next?
June 28, 2023
From Motley Fool
Genmab/AbbVie's Blood Cancer Treatment Shows 82% Response Rate In Pretreated Follicular Lymphoma Patients
June 28, 2023
From Benzinga
7 Stocks That Every 40-Year-Old Should Buy Today
June 27, 2023
From InvestorPlace
Quant Ratings Updated on 90 Stocks
June 27, 2023
From InvestorPlace
From InvestorPlace
Why CollPlant Biotechnologies Stock Is Trading Higher
June 26, 2023
From Benzinga
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
June 26, 2023
From Benzinga
Tickers
ABBV
From Motley Fool
From Motley Fool
Cramer Says Datadog Will 'Put Up Some Good Numbers,' And 9 More Stock Takes From 'Mad Money' Host
June 23, 2023
From Benzinga
2 No-Brainer Healthcare Stocks to Buy Right Now
June 22, 2023
From Motley Fool
Alleged Industrial Espionage Makes an Interesting Story
June 21, 2023
From Motley Fool
RegenXbio's Potential Blockbuster: Analyst is Bullish On Stock Citing Potential Gains From AAV Gene Therapies Resurgence
June 20, 2023
From Benzinga
From InvestorPlace
From Benzinga
Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions
June 19, 2023
From Motley Fool
Unlock the Potential of These 7 Cash-Flow Machines
June 18, 2023
From InvestorPlace
From Motley Fool
AbbVie vs Coherus: Dispute Emerges over Upcoming Launch of Low-Cost Biosimilar, Yusimry
June 15, 2023
From Benzinga
From Benzinga
From Benzinga
Negotiation or Coercion? Big Pharma and US Chamber of Commerce Tackle Government on Drug Prices
June 12, 2023
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.